Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ)
CNY 5.2
(0.78%)
CNY 5.2
(0.78%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.67 Million CNY | -78.32% |
| 2022 | 179.49 Million CNY | -15.86% |
| 2021 | 215.47 Million CNY | 7.61% |
| 2020 | 216.52 Million CNY | -0.84% |
| 2019 | 220.97 Million CNY | -32.83% |
| 2018 | 320.57 Million CNY | 18.75% |
| 2017 | 239.64 Million CNY | -1.04% |
| 2016 | 265.92 Million CNY | 97.11% |
| 2015 | 108.66 Million CNY | 474.5% |
| 2014 | -129.84 Million CNY | -139.22% |
| 2013 | 90.85 Million CNY | 4959.55% |
| 2012 | -15.48 Million CNY | -102.18% |
| 2011 | 83.47 Million CNY | 8.76% |
| 2010 | 80.26 Million CNY | 26.37% |
| 2009 | 85.41 Million CNY | -60.9% |
| 2008 | 156.75 Million CNY | -53.93% |
| 2007 | 324.32 Million CNY | 420.92% |
| 2006 | 69.98 Million CNY | 15.82% |
| 2005 | 60.26 Million CNY | 24.61% |
| 2004 | 48.36 Million CNY | -7.53% |
| 2003 | 52.3 Million CNY | -9.82% |
| 2002 | 58 Million CNY | -5.8% |
| 2001 | 61.57 Million CNY | 10.41% |
| 2000 | 54.72 Million CNY | -7.54% |
| 1999 | 60.32 Million CNY | 12.54% |
| 1998 | 52.22 Million CNY | 15.9% |
| 1997 | 46.24 Million CNY | 68.9% |
| 1996 | 27.38 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -40.41 Million CNY | -40.93% |
| 2024 Q1 | -43.96 Million CNY | -67.53% |
| 2024 Q2 | -28.67 Million CNY | -28.26% |
| 2023 Q3 | -28.31 Million CNY | -195.55% |
| 2023 Q4 | -37.2 Million CNY | -31.42% |
| 2023 Q1 | -41.58 Million CNY | -168.41% |
| 2023 FY | - CNY | -78.32% |
| 2023 Q2 | 29.62 Million CNY | 171.25% |
| 2022 FY | - CNY | -15.86% |
| 2022 Q4 | 60.79 Million CNY | 2613.02% |
| 2022 Q1 | 15.88 Million CNY | -65.74% |
| 2022 Q2 | 23.36 Million CNY | 47.07% |
| 2022 Q3 | -2.41 Million CNY | -110.35% |
| 2021 FY | - CNY | 7.61% |
| 2021 Q1 | 22.29 Million CNY | -47.16% |
| 2021 Q2 | 48.45 Million CNY | 117.28% |
| 2021 Q3 | 24.49 Million CNY | -49.45% |
| 2021 Q4 | 46.37 Million CNY | 89.35% |
| 2020 FY | - CNY | -0.84% |
| 2020 Q4 | 42.2 Million CNY | 2.08% |
| 2020 Q2 | 43.35 Million CNY | 4725.19% |
| 2020 Q3 | 41.34 Million CNY | -4.65% |
| 2020 Q1 | -937.46 Thousand CNY | 93.81% |
| 2019 Q1 | 46.18 Million CNY | 4.45% |
| 2019 Q3 | 57.08 Million CNY | 13.5% |
| 2019 Q4 | -15.14 Million CNY | -126.53% |
| 2019 FY | - CNY | -32.83% |
| 2019 Q2 | 50.29 Million CNY | 8.9% |
| 2018 Q1 | 134.99 Million CNY | 238.24% |
| 2018 FY | - CNY | 18.75% |
| 2018 Q4 | 44.22 Million CNY | 73.38% |
| 2018 Q3 | 25.5 Million CNY | -31.72% |
| 2018 Q2 | 37.35 Million CNY | -72.33% |
| 2017 Q4 | 39.91 Million CNY | -13.38% |
| 2017 FY | - CNY | -1.04% |
| 2017 Q1 | 40.43 Million CNY | 23.92% |
| 2017 Q2 | 53.81 Million CNY | 33.1% |
| 2017 Q3 | 46.07 Million CNY | -14.38% |
| 2016 Q1 | 38 Million CNY | -47.41% |
| 2016 Q2 | 42.57 Million CNY | 12.0% |
| 2016 Q4 | 32.62 Million CNY | -62.17% |
| 2016 FY | - CNY | 97.11% |
| 2016 Q3 | 86.24 Million CNY | 102.59% |
| 2015 Q4 | 72.27 Million CNY | 929.9% |
| 2015 FY | - CNY | 474.5% |
| 2015 Q3 | 7.01 Million CNY | -15.24% |
| 2015 Q2 | 8.27 Million CNY | 233.63% |
| 2015 Q1 | -6.19 Million CNY | 89.15% |
| 2014 FY | - CNY | -139.22% |
| 2014 Q4 | -57.12 Million CNY | -67.09% |
| 2014 Q3 | -34.18 Million CNY | -503.76% |
| 2014 Q2 | 8.46 Million CNY | 161.55% |
| 2014 Q1 | -13.75 Million CNY | -129.79% |
| 2013 FY | - CNY | 4959.55% |
| 2013 Q4 | 46.18 Million CNY | 54419.43% |
| 2013 Q3 | 84.7 Thousand CNY | -99.51% |
| 2013 Q2 | 17.2 Million CNY | 348.61% |
| 2013 Q1 | -6.92 Million CNY | 60.89% |
| 2012 FY | - CNY | -102.18% |
| 2012 Q1 | -4.9 Million CNY | -465.9% |
| 2012 Q3 | -21.87 Million CNY | -11.0% |
| 2012 Q2 | -19.7 Million CNY | -301.54% |
| 2012 Q4 | -17.69 Million CNY | 19.1% |
| 2011 Q2 | 16.23 Million CNY | 66.53% |
| 2011 Q1 | 9.74 Million CNY | -32.33% |
| 2011 FY | - CNY | 8.76% |
| 2011 Q4 | 1.34 Million CNY | -87.46% |
| 2011 Q3 | 10.69 Million CNY | -34.14% |
| 2010 Q3 | -939.35 Thousand CNY | -107.8% |
| 2010 Q4 | 14.4 Million CNY | 1633.74% |
| 2010 FY | - CNY | 26.37% |
| 2010 Q1 | 4.46 Million CNY | 173.33% |
| 2010 Q2 | 12.05 Million CNY | 170.07% |
| 2009 Q2 | 8.45 Million CNY | 21.01% |
| 2009 Q4 | -6.08 Million CNY | -131.98% |
| 2009 FY | - CNY | -60.9% |
| 2009 Q3 | 19.02 Million CNY | 125.07% |
| 2009 Q1 | 6.98 Million CNY | 243.35% |
| 2008 FY | - CNY | -53.93% |
| 2008 Q4 | -4.87 Million CNY | -126.45% |
| 2008 Q3 | 18.42 Million CNY | -35.38% |
| 2008 Q2 | 28.5 Million CNY | -66.5% |
| 2008 Q1 | 85.09 Million CNY | -23.52% |
| 2007 Q3 | 141.72 Million CNY | 159.69% |
| 2007 Q4 | 111.26 Million CNY | -21.49% |
| 2007 Q2 | 54.57 Million CNY | 433.61% |
| 2007 Q1 | 10.22 Million CNY | -44.78% |
| 2007 FY | - CNY | 420.92% |
| 2006 Q1 | 16.37 Million CNY | 0.86% |
| 2006 Q2 | 16.22 Million CNY | -0.92% |
| 2006 Q3 | 18.76 Million CNY | 15.67% |
| 2006 Q4 | 18.51 Million CNY | -1.33% |
| 2006 FY | - CNY | 15.82% |
| 2005 FY | - CNY | 24.61% |
| 2005 Q2 | 11.15 Million CNY | -26.62% |
| 2005 Q4 | 16.23 Million CNY | -3.17% |
| 2005 Q1 | 15.2 Million CNY | 35.96% |
| 2005 Q3 | 16.76 Million CNY | 50.29% |
| 2004 FY | - CNY | -7.53% |
| 2004 Q4 | 11.18 Million CNY | -5.72% |
| 2004 Q3 | 11.86 Million CNY | -10.99% |
| 2004 Q1 | 11.58 Million CNY | 16.46% |
| 2004 Q2 | 13.32 Million CNY | 14.99% |
| 2003 Q4 | 9.95 Million CNY | -18.43% |
| 2003 Q2 | 16 Million CNY | 12.49% |
| 2003 FY | - CNY | -9.82% |
| 2003 Q1 | 14.23 Million CNY | 133.65% |
| 2003 Q3 | 12.19 Million CNY | -23.8% |
| 2002 Q1 | -8.25 Million CNY | 0.0% |
| 2002 Q4 | 6.09 Million CNY | -35.25% |
| 2002 Q3 | 9.4 Million CNY | -70.13% |
| 2002 Q2 | 31.49 Million CNY | 481.76% |
| 2002 FY | - CNY | -5.8% |
| 2001 FY | - CNY | 10.41% |
| 2000 FY | - CNY | -7.54% |
| 1999 FY | - CNY | 12.54% |
| 1998 FY | - CNY | 15.9% |
| 1997 FY | - CNY | 68.9% |
| 1996 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 1.14 Billion CNY | 100.234% |
| Zhejiang Zhenyuan Share Co., Ltd. | 220.46 Million CNY | 101.212% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | -83.34 Million CNY | 96.794% |
| Yifan Pharmaceutical Co., Ltd. | -483.52 Million CNY | 99.447% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 66.15 Million CNY | 104.039% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 4.85 Billion CNY | 100.055% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 116.49 Million CNY | 102.293% |
| Boai NKY Medical Holdings Ltd. | 665.28 Million CNY | 100.402% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 391.09 Million CNY | 100.683% |